Study in Patients With Asthma

• Status: Completed
• Trial end date: 2005-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the most safe and effective dose of the investigational drug in comparison with a control drug and placebo.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dey
• Treatments: Formoterol Fumarate

Criteria

Inclusion Criteria:

• Children with a history of asthma

• Written guardian approval

Exclusion Criteria:

• Current or recent asthma exacerbation, requiring hospitalization

• History of smoking

• Debilitating or systemic and/or life-threatening diseases.